Carlo Wilke

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia”.

Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia

New England Journal of Medicine(2022)10.1056/nejmoa2207406

N/A

0.831DataRank · unranked

253 citations

Matt C. Danzi, Carlo Wilke, M. Renaud, Sarah Fazal, Marie‐Josée Dicaire +46 more

Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3

Annals of Neurology(2023)10.1002/ana.26824

N/A

0.505DataRank · unranked

28 citations

Moritz Berger, Carlo Wilke, Jeannette Hübener‐Schmid, Tamara Schaprian, Magda M. Santana +34 more

Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51518

N/A

0.345DataRank · unranked

9 citations

Lina María Serna-Higuita, Carlo Wilke, Tim W. Rattay, Holger Hengel, Jennifer Reichbauer +8 more

Intronic FGF14 GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment response

medRxiv(2023)10.1101/2023.07.30.23293380

N/A

0DataRank · unranked

10 citations

Felix Heindl, Carlo Wilke, Matt C. Danzi, Andreas Traschütz, Catherine Ashton +12 more

GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort

EBioMedicine(2024)10.1016/j.ebiom.2024.105076

N/A

0DataRank · unranked

66 citations

Felix Heindl, Carlo Wilke, Matt C. Danzi, Andreas Traschütz, Catherine Ashton +12 more

Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia

Annals of Clinical and Translational Neurology(2021)10.1002/acn3.51358

N/A

0DataRank · unranked

18 citations

Lina María Serna-Higuita, Tim W. Rattay, Walter Maetzler, Isabel Wurster, Stefanie N. Hayer +8 more

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration(2025)10.1080/21678421.2025.2557936

N/A

0DataRank · unranked

0 citations

Carlo Wilke, Holger Hengel, Tim W. Rattay, Aleksandra Maleska Maceski, Jens Kühle +3 more

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4

International Journal of Molecular Sciences(2022)10.3390/ijms232113466

N/A

0DataRank · unranked

9 citations

Christoph Ruschil, Ahmed Abdelhak, Carlo Wilke, Aleksandra Maleska, Jens Kühle +4 more

Stage-dependent biomarker changes in spinocerebellar ataxia type 3

medRxiv(2023)10.1101/2023.04.21.23287817

N/A

0DataRank · unranked

10 citations

Moritz Berger, Carlo Wilke, Jeannette Hübener‐Schmid, Tamara Schaprian, Magda M. Santana +34 more